Glioma stem cells as a target for treatment.
Standard
Glioma stem cells as a target for treatment. / Lamszus, Katrin; Günther, Hauke.
In: TARGET ONCOL, Vol. 5, No. 3, 3, 2010, p. 211-215.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Glioma stem cells as a target for treatment.
AU - Lamszus, Katrin
AU - Günther, Hauke
PY - 2010
Y1 - 2010
N2 - Glioma cells with stem cell-like properties represent a minor subfraction of the total tumor cell population. These cells are highly chemo- and radioresistent and are held responsible for the inevitable recurrence of malignant gliomas. This review summarizes current strategies for targeting putative glioma stem cells. Target definition approaches comprise extrapolation and adaptation of therapies from general oncology, target identification by correlative molecular genetic analyses, and dedicated target discovery research. Targeting strategies include inhibition of tumor-specific signaling pathways, enhancement of tumor cell differentiation, radiosensitization, indirect targeting of the tumor stem cell niche, oncolytic virotherapy, and adhesion molecule blockade.
AB - Glioma cells with stem cell-like properties represent a minor subfraction of the total tumor cell population. These cells are highly chemo- and radioresistent and are held responsible for the inevitable recurrence of malignant gliomas. This review summarizes current strategies for targeting putative glioma stem cells. Target definition approaches comprise extrapolation and adaptation of therapies from general oncology, target identification by correlative molecular genetic analyses, and dedicated target discovery research. Targeting strategies include inhibition of tumor-specific signaling pathways, enhancement of tumor cell differentiation, radiosensitization, indirect targeting of the tumor stem cell niche, oncolytic virotherapy, and adhesion molecule blockade.
M3 - SCORING: Zeitschriftenaufsatz
VL - 5
SP - 211
EP - 215
JO - TARGET ONCOL
JF - TARGET ONCOL
SN - 1776-2596
IS - 3
M1 - 3
ER -